方舟健客 06086Prospectus Information

Prospectus Information
返回 Stock Info Prospectus Allotment Results Allotment Profile Expected Lots
IPO Timeline
Broker Deadline
2024-07-04
Morning deadline
HKEX Deadline
2024-07-04
Noon deadline
Broker Results (T-2)
2024-07-05
Some brokers release in afternoon
Grey Market (T-1)
2024-07-08
Afternoon
HKEX Allotment (T-1)
2024-07-08
Evening
Registrar Allotment (T-1)
2024-07-08
Evening
Listing Day (T)
2024-07-09
First day of trading
Company Overview
Stock Name方舟健客
Stock Code06086
Company Full Name方舟健客
Industry醫療保健
Principal Activities公司是是中國最大的在線慢病管理平臺，為不斷增長的慢病患者提供覆蓋整個疾病周期的定制醫療護理及精準醫療，目標為將覆蓋整個疾病周期的服務推廣至更廣泛的疾病領域。
Listing Date2024-07-09
Listing Rules EraOld Rules
Listing Rules ChapterTo be extracted
Weighted Voting Rights (WVR)No
Registered Address (Mainland China)中國廣東省廣州市黃埔區蘿崗科學城科學大道99號科匯金谷S棟四街一至二樓
Business Address (Hong Kong)To be extracted
Place of IncorporationTo be extracted
Listing MethodTo be extracted
Listing BoardMain Board
Websitehttp://investors.jianke.com/
Share Registrar卓佳证券登记有限公司 (Tricor Investor Services Limited)
Registrar Contact(852)2862 8628
A-Share/US Dual ListingNo
Offering Information
Offering Mechanism To be extracted
Offer PriceHK$ 8.18 / shares
Offer Price RangeTo be extracted
Lot SizeTo be extracted
Entry ThresholdTo be extracted
Par ValueTo be extracted
Offer PeriodTo be extracted
Global Offering SharesTo be extracted
HK Public Offer Shares (Initial)To be extracted
Public Offer Lots (Initial)To be extracted
International Placing Shares (Initial)To be extracted
Offer RatioTo be extracted
Total Shares Post-IPOTo be extracted
Greenshoe (Over-allotment Option)Yes
Stabilizing Manager (Greenshoe)花旗环球金融亚洲有限公司 CE AAA137
Cornerstone Share0%
Clawback TiersTo be extracted
Reallocation OptionNo
Total Global Offering SizeHK$ 58,405,200
Subscription Tiers

Minimum subscription unit: 1 lot. Subscription amount ≤ HK$5,000,000 is Pool A, > HK$5,000,000 is Pool B.

Pool A
Lots SubscribedShares SubscribedSubscription Amount (HKD)
1 lots 500 HK$ 4,090
2 lots 1,000 HK$ 8,180
3 lots 1,500 HK$ 12,270
4 lots 2,000 HK$ 16,360
5 lots 2,500 HK$ 20,450
6 lots 3,000 HK$ 24,540
7 lots 3,500 HK$ 28,630
8 lots 4,000 HK$ 32,720
9 lots 4,500 HK$ 36,810
10 lots 5,000 HK$ 40,900
12 lots 6,000 HK$ 49,080
14 lots 7,000 HK$ 57,260
16 lots 8,000 HK$ 65,440
18 lots 9,000 HK$ 73,620
20 lots 10,000 HK$ 81,800
30 lots 15,000 HK$ 122,700
40 lots 20,000 HK$ 163,600
50 lots 25,000 HK$ 204,500
60 lots 30,000 HK$ 245,400
70 lots 35,000 HK$ 286,300
80 lots 40,000 HK$ 327,200
90 lots 45,000 HK$ 368,100
100 lots 50,000 HK$ 409,000
120 lots 60,000 HK$ 490,800
140 lots 70,000 HK$ 572,600
160 lots 80,000 HK$ 654,400
180 lots 90,000 HK$ 736,200
200 lots 100,000 HK$ 818,000
400 lots 200,000 HK$ 1,636,000
600 lots 300,000 HK$ 2,454,000
800 lots 400,000 HK$ 3,272,000
1,000 lots 500,000 HK$ 4,090,000
1,200 lots 600,000 HK$ 4,908,000
Pool B
Lots SubscribedShares SubscribedSubscription Amount (HKD)
1,400 lots 700,000 HK$ 5,726,000
2,380 lots 1,190,000 HK$ 9,734,200
Valuation & Financials
Market Cap (at Offer Price)To be extracted
Pre-IPO Valuation (Last Round)To be extracted
P/E RatioTo be extracted
Profit/Loss StatusTo be extracted
Period-End Cash BalanceTo be extracted
Listing ExpensesTo be extracted
Listing Expenses / Funds RaisedTo be extracted
Total Pre-IPO InvestmentTo be extracted
First Day Performance
First Day CloseHK$ 4.53
First Day OpenHK$ 4.68
First Day Change-44.62%
First Day Volume9892000.0
First Day Turnover46415800.0
Use of Proceeds
Use of Proceeds1、約67.4%或42.51百萬港元將于未來三至五年用于拓展業務； 2、約16.0%或10.09百萬港元將于未來五年用于研發活動； 3、約11.6%或7.32百萬港元將用于公司對在線慢性疾病管理行業價值鏈中的其他利益相關者的潛在投資和收購或戰略聯盟； 4、約5.0%或3.15百萬港元將用作公司的運營資金和一般公司用途。
Underwriting Syndicate
Joint Sponsors (2)
花旗环球金融亚洲有限公司 CE AAA137 农银国际融资有限公司 CE AWL249
Overall Coordinators (5)
花旗环球金融亚洲有限公司 CE AAA137 农银国际证券有限公司 CE ACX411 安信国际证券(香港)有限公司 工银国际证券有限公司 CE ARO299 中国银河国际证券（香港）有限公司 CE AXM459
Joint Bookrunners (19)
花旗环球金融亚洲有限公司 CE AAA137 农银国际证券有限公司 CE ACX411 安信国际证券(香港)有限公司 工银国际证券有限公司 CE ARO299 中国银河国际证券（香港）有限公司 CE AXM459 中国光大证券（香港）有限公司 CE AAW536 招商证券（香港）有限公司 CE AAI650 巨诚证券有限公司 CE BPX754 招银国际融资有限公司 CE AVM940 复星国际证券有限公司 CE AAF432 富途证券国际（香港）有限公司 CE AZT137 GF Securities (Hong Kong) Brokerage Limited CE AOB364 华泰金融控股（香港）有限公司 CE AOK809 Long Bridge HK Limited CE BPX066 申万宏源证券（香港）有限公司 CE AAC927 老虎证券（香港）环球有限公司 CE BMU940 胜利证券有限公司 CE ABN091 越秀证券有限公司 CE ABQ722 中泰国际证券有限公司 CE BAA855
Joint Lead Managers (19)
花旗环球金融亚洲有限公司 CE AAA137 农银国际证券有限公司 CE ACX411 安信国际证券(香港)有限公司 工银国际证券有限公司 CE ARO299 中国银河国际证券（香港）有限公司 CE AXM459 中国光大证券（香港）有限公司 CE AAW536 招商证券（香港）有限公司 CE AAI650 巨诚证券有限公司 CE BPX754 招银国际融资有限公司 CE AVM940 复星国际证券有限公司 CE AAF432 富途证券国际（香港）有限公司 CE AZT137 GF Securities (Hong Kong) Brokerage Limited CE AOB364 华泰金融控股（香港）有限公司 CE AOK809 Long Bridge HK Limited CE BPX066 申万宏源证券（香港）有限公司 CE AAC927 老虎证券（香港）环球有限公司 CE BMU940 胜利证券有限公司 CE ABN091 越秀证券有限公司 CE ABQ722 中泰国际证券有限公司 CE BAA855
Service Providers
RoleInstitution
Stabilizing Manager 花旗环球金融亚洲有限公司 CE AAA137
Cornerstone Investors
This stock has no cornerstone investors.
Directors & Management
ChairmanDavid McKee HAND
Company Secretary鄒宇鳴;伍秀薇
No director data available.
Major Shareholders
Major Shareholders & HoldingsCrescent Point投資實體(32.64%);Fangrong Management Limited(19.81%);Celaeno Group Limited(13.89%)
AI AI Analysis
!
The following content is generated by an AI model based on historical IPO data. It does NOT constitute investment advice, solicitation, or recommendation. Past subscription patterns and post-listing performance do not guarantee future results. Data may contain inaccuracies — always verify against official HKEX filings and prospectuses before making any investment decision.

Market Sentiment

The IPO was 16.63 times oversubscribed, indicating moderate market enthusiasm. The overall hit rate of 63.81% suggests relatively broad allocations, typical for a less aggressively sought offering. Final pricing at HK$8.18 reflected stable demand without a clear signal of severe underpricing or overpricing. (This is AI-generated commentary based on historical data. Past patterns do not guarantee future outcomes. Not financial advice.)

Tier Analysis

The data reveals a classic inefficiency: the last A-tier applicant (HK$600,000) and the first B-tier applicant (HK$700,000) both received only 1 expected lot, making the additional HK$100,000 in the B-head subscription yield no marginal benefit. This dulls the incentive to cross into B-head territory and may reflect a poorly calibrated threshold. (This is AI-generated commentary based on historical data. Past patterns do not guarantee future outcomes. Not financial advice.)

Demographics

Demographic details such as mainland participation, gender, or regional distribution are not available in the provided data, precluding any analysis of applicant population trends. Without this information, no meaningful demographic conclusions can be drawn. (This is AI-generated commentary based on historical data. Past patterns do not guarantee future outcomes. Not financial advice.)

AI-generated content. For informational purposes only. Not financial advice. Verify against official sources.
Subscription Tiers
IPO Timeline
Disclaimer & Risk Warning

Site Nature: This website (cibo.qizai.ai) is an independent technology product showcase platform established by Panda Securities Limited (CE Number: BNC380). This website itself and all content displayed herein do not constitute and are not involved in any regulated activity or licensed service.

Not Investment Advice: The data on this page is automatically extracted from prospectus PDFs by AI and may contain omissions or errors. All information and data on this page are sourced from prospectuses and related historical documents, are not real-time data, and will not be automatically updated, reflecting historical information at the time of prospectus publication. All content is provided solely for AI tool analysis learning exchange and technical reference purposes, and absolutely does not constitute any investment advice, offer to buy or sell, solicitation, recommendation, or guarantee. The output of this AI analysis tool should not be interpreted as investment opinion.

Decision Responsibility: Users should make investment decisions based on their own independent judgment and consult independent licensed financial advisors when needed. Neither the Company nor this AI analysis tool shall bear any responsibility for any investment decisions made by users based on the information on this page.

Separation from Panda Securities Official Website: The content of this website is strictly distinct from the SFC-regulated licensed services provided by Panda Securities' official website (fafa.hk). No securities trading or account opening or other regulated operations can be conducted through this website.

Panda Securities Limited is a licensed corporation regulated by the Hong Kong SFC (CE Number: BNC380) and a Hong Kong Exchange Participant (Participant ID: 02229). Use of this website constitutes acceptance of this disclaimer.

Cibo — IPO & Market Data Analytics